Literature DB >> 26697836

Deubiquitinating c-Myc: USP36 steps up in the nucleolus.

Xiao-Xin Sun1, Rosalie C Sears1, Mu-Shui Dai1.   

Abstract

Ubiquitination plays a key and complex role in the regulation of c-Myc stability, transactivation, and oncogenic activity. c-Myc is ubiquitinated by a number of ubiquitin ligases (E3s), such as SCF(Fbw7) and SCF(Skp2). Depending on the E3s, ubiquitination can either positively or negatively regulate c-Myc levels and activity. Meanwhile, c-Myc ubiquitination can be reversed by deubiquitination. An early study showed that USP28 deubiquitinates c-Myc via interacting with Fbw7α whereas a recent study reveals that USP37 deubiquitinates c-Myc independently of Fbw7 and c-Myc phosphorylation. Consequently, both USP28 and USP37 stabilize c-Myc and enhance its activity. We recently found the nucleolar USP36 as a novel c-Myc deubiquitinase that controls the end-point of c-Myc degradation pathway in the nucleolus. Here we briefly review the current understanding of ubiquitination and deubiquitination regulation of c-Myc and further discuss the USP36-c-Myc regulatory pathway.

Entities:  

Keywords:  USP36; c-Myc; deubiquitinating enzymes; nucleolus; ubiquitination

Mesh:

Substances:

Year:  2015        PMID: 26697836      PMCID: PMC4825782          DOI: 10.1080/15384101.2015.1093713

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  69 in total

1.  Ras enhances Myc protein stability.

Authors:  R Sears; G Leone; J DeGregori; J R Nevins
Journal:  Mol Cell       Date:  1999-02       Impact factor: 17.970

2.  Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.

Authors:  Masayoshi Yada; Shigetsugu Hatakeyama; Takumi Kamura; Masaaki Nishiyama; Ryosuke Tsunematsu; Hiroyuki Imaki; Noriko Ishida; Fumihiko Okumura; Keiko Nakayama; Keiichi I Nakayama
Journal:  EMBO J       Date:  2004-04-22       Impact factor: 11.598

3.  Degradation of nuclear oncoproteins by the ubiquitin system in vitro.

Authors:  A Ciechanover; J A DiGiuseppe; B Bercovich; A Orian; J D Richter; A L Schwartz; G M Brodeur
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

Review 4.  An overview of MYC and its interactome.

Authors:  Maralice Conacci-Sorrell; Lisa McFerrin; Robert N Eisenman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

5.  Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis.

Authors:  B Lutterbach; S R Hann
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

6.  The Drosophila F box protein archipelago regulates dMyc protein levels in vivo.

Authors:  Kenneth H Moberg; Ashim Mukherjee; Alexey Veraksa; Spyros Artavanis-Tsakonas; Iswar K Hariharan
Journal:  Curr Biol       Date:  2004-06-08       Impact factor: 10.834

7.  myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome.

Authors:  E M Flinn; C M Busch; A P Wright
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

Review 8.  MYC degradation.

Authors:  Amy S Farrell; Rosalie C Sears
Journal:  Cold Spring Harb Perspect Med       Date:  2014-03-01       Impact factor: 6.915

9.  Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc.

Authors:  S E Salghetti; S Y Kim; W P Tansey
Journal:  EMBO J       Date:  1999-02-01       Impact factor: 11.598

10.  Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles.

Authors:  Susanne Walz; Francesca Lorenzin; Jennifer Morton; Katrin E Wiese; Björn von Eyss; Steffi Herold; Lukas Rycak; Hélène Dumay-Odelot; Saadia Karim; Marek Bartkuhn; Frederik Roels; Torsten Wüstefeld; Matthias Fischer; Martin Teichmann; Lars Zender; Chia-Lin Wei; Owen Sansom; Elmar Wolf; Martin Eilers
Journal:  Nature       Date:  2014-07-09       Impact factor: 49.962

View more
  14 in total

Review 1.  Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer.

Authors:  Shan Wang; Dede N Ekoue; Ganesh V Raj; Ralf Kittler
Journal:  Cancer Lett       Date:  2018-09-11       Impact factor: 8.679

2.  SUMO protease SENP1 deSUMOylates and stabilizes c-Myc.

Authors:  Xiao-Xin Sun; Yingxiao Chen; Yulong Su; Xiaoyan Wang; Krishna Mohan Chauhan; Juan Liang; Colin J Daniel; Rosalie C Sears; Mu-Shui Dai
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-10       Impact factor: 11.205

3.  Skp2 is over-expressed in breast cancer and promotes breast cancer cell proliferation.

Authors:  Wenwen Zhang; Lulu Cao; Zijia Sun; Jing Xu; Lin Tang; Weiwei Chen; Jiayan Luo; Fang Yang; Yucai Wang; Xiaoxiang Guan
Journal:  Cell Cycle       Date:  2016-04-25       Impact factor: 4.534

4.  Regulation of USP37 Expression by REST-Associated G9a-Dependent Histone Methylation.

Authors:  Tara H W Dobson; Rashieda J Hatcher; Jyothishmathi Swaminathan; Chandra M Das; Shavali Shaik; Rong-Hua Tao; Ciro Milite; Sabrina Castellano; Pete H Taylor; Gianluca Sbardella; Vidya Gopalakrishnan
Journal:  Mol Cancer Res       Date:  2017-05-08       Impact factor: 5.852

Review 5.  Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy.

Authors:  Liangliang Xing; Leidi Xu; Yong Zhang; Yinggang Che; Min Wang; Yongxiang Shao; Dan Qiu; Honglian Yu; Feng Zhao; Jian Zhang
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

6.  Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers.

Authors:  Caroline C Farrington; Eric Yuan; Sahar Mazhar; Sudeh Izadmehr; Lauren Hurst; Brittany L Allen-Petersen; Mahnaz Janghorban; Eric Chung; Grace Wolczanski; Matthew Galsky; Rosalie Sears; Jaya Sangodkar; Goutham Narla
Journal:  J Biol Chem       Date:  2019-12-10       Impact factor: 5.157

Review 7.  Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors.

Authors:  Shiyao Chen; Yunqi Liu; Huchen Zhou
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

Review 8.  Strategies to Inhibit Myc and Their Clinical Applicability.

Authors:  Jonathan R Whitfield; Marie-Eve Beaulieu; Laura Soucek
Journal:  Front Cell Dev Biol       Date:  2017-02-23

Review 9.  Targeting the MYC Ubiquitination-Proteasome Degradation Pathway for Cancer Therapy.

Authors:  Xiao-Xin Sun; Yanping Li; Rosalie C Sears; Mu-Shui Dai
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244

10.  Stress-induced epinephrine enhances lactate dehydrogenase A and promotes breast cancer stem-like cells.

Authors:  Bai Cui; Yuanyuan Luo; Pengfei Tian; Fei Peng; Jinxin Lu; Yongliang Yang; Qitong Su; Bing Liu; Jiachuan Yu; Xi Luo; Liu Yin; Wei Cheng; Fan An; Bin He; Dapeng Liang; Sijin Wu; Peng Chu; Luyao Song; Xinyu Liu; Huandong Luo; Jie Xu; Yujia Pan; Yang Wang; Dangsheng Li; Peng Huang; Qingkai Yang; Lingqiang Zhang; Binhua P Zhou; Suling Liu; Guowang Xu; Eric W-F Lam; Keith W Kelley; Quentin Liu
Journal:  J Clin Invest       Date:  2019-01-28       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.